Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Polycystic Ovary Syndrome Treatment Market, By Drug Class, By Distribution Channel, By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

This report provides in-depth analysis of the global Polycystic Ovary Syndrome (PCOS) Treatment market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.

Company Profiles

Polycystic Ovarian Syndrome (PCOS) can be described as small sacs filled with fluid develop on the ovaries as a result of the endocrine system condition. Women with PCOS who are of childbearing age are affected. PCOS-positive women are more likely to experience miscarriage, gestational diabetes, pregnancy-induced hypertension, preeclampsia, and early birth. Moreover, women with PCOS may experience irregular menstrual cycles, elevated androgen (sex hormone) levels, excessive hair growth, acne, and obesity.

Women who have PCOS are more likely to develop serious health issues. These include type 2 diabetes, high blood pressure, heart and blood vessel problems, and uterine cancer. Women suffering from PCOS frequently struggle to conceive (fertility).

Market Dynamics:

Effective use of oral contraceptives and increasing product value can drive the polycystic ovary syndrome (PCOS) treatment market over the forecast period. For instance, in August 2022, an article was published in the NCBI, according to which, for the treatment of PCOS, the major mechanism of action of oral contraceptives (OCs) is to control menstruation. These drugs also reduce hirsutism and acne by lowering testosterone levels. Thus, oral contraceptives are primary treatment for the polycystic ovary syndrome.

Moreover, rising awareness about novel mechanisms in the treatment of Polycystic Ovary Syndrome (PCOS) is anticipated to boost the growth of the market over the forecast period. For instance, according to research study published by Department of Obstetrics and Gynecology, China in November 2020, stated that the electroacupuncture (EA) intervention alleviated PCOS-like symptoms in rats by improving IR, mitochondrial dysfunction and oxidative stress through regulation of SREBP1, a regulator of lipid metabolism. The study findings illuminate the novel protective mechanisms of EA in the treatment of PCOS.

Key features of the study:

Key Attributes:

Report AttributeDetails
No. of Pages177
Forecast Period2023 - 2030
Estimated Market Value (USD) in 2023$1086.6 Million
Forecasted Market Value (USD) by 2030$1514.6 Million
Compound Annual Growth Rate4.8%
Regions CoveredGlobal

Key Topics Covered:

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Polycystic Ovary Syndrome (PCOS) Treatment Market - Impact of Coronavirus (Covid-19) Pandemic

5. Global Polycystic Ovary Syndrome (PCOS) Treatment Market, By Drug Class, 2017 -2030, (US$ Million)

6. Global Polycystic Ovary Syndrome (PCOS) Treatment Market, By Distribution Channel, 2017 -2030, (US$ Million)

7. Global Polycystic Ovary Syndrome (PCOS) Treatment Market, By Region, 2017 -2030, (US$ Million)

8. Competitive Landscape

9. Section

For more information about this report visit https://www.researchandmarkets.com/r/kn3858

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment